Alliance Pharma PLC (LON:APH) has acquired US-based consumer healthcare company Biogix Inc for a total of US$110mln cash. The AIM-listed company said the addition of Biogix and its fast-growing Amberen treatment for menopause symptoms would be immediately earnings enhancing in the 2021 calendar year and is expected to be “significantly earnings enhancing” from 2022. Primarily Read more…